Search | Page 4 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Hematopoietic Cell Transplantation in Myelodysplastic Syndromes after Treatment with Hypomethylating Agents

    ... The prognosis of patients with myelodysplastic syndromes (MDS) following failure of hypomethylating agent (HMA) therapy is ...

    Research Article last updated 06/26/2017 - 9:13am.

  2. Deregulation of innate immune and inflammatory signaling in myelodysplastic syndromes

    ... March 12, 2015 Myelodysplastic syndromes are a group of heterogeneous clonal hematologic malignancies that ...

    Research Article last updated 06/21/2017 - 11:10am.

  3. Evolution of NPM1-negative therapy-related myelodysplastic syndromes following curative treatment of NPM1-mutant AML

    ... Bone Marrow Diseases:  myelodysplastic syndromes (MDS) ...

    Research Article last updated 07/18/2017 - 12:51pm.

  4. Newark

    ... for Future Therapies 1.4 MB Myelodysplastic Syndromes: Understanding Your Diagnosis and Current and Emerging Treaments ...

    Conference Event last updated 09/19/2017 - 10:52am.

  5. Adding molecular data to prognostic models can improve predictive power in treated patients with myelodysplastic syndromes

    ...

    Research Article last updated 09/13/2017 - 8:49am.

  6. Clinical trial reveals genetic fault that reduces the effectiveness of leukemia treatment

    ... times for people with acute myeloid leukaemia (AML) or myelodysplastic syndrome (MDS) could be improved by adding a biological drug ... acute myeloid leukemia (AML) myelodysplastic syndromes (MDS) ...

    Research Article last updated 09/29/2017 - 10:32am.

  7. Patterns of treatment and costs associated with transfusion burden in patients with myelodysplastic syndromes.

    ... Transfusion dependence (TD) among myelodysplastic syndromes (MDS) patients negatively impacts survival and health-related ...

    Research Article last updated 05/22/2017 - 11:01am.

  8. Prognostic relevance of lymphocytopenia, monocytopenia and lymphocyte-to-monocyte ratio in primary myelodysplastic syndromes: a single center experience in 889 patients

    ... Current prognostic models for myelodysplastic syndromes (MDS), including the Revised International Prognostic Scoring ...

    Research Article last updated 05/02/2017 - 10:37am.

  9. Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes

    ... MAC with RIC in patients with acute myeloid leukemia or myelodysplastic syndromes . Patients and Methods Patients age 18 to 65 years with HCT ...

    Research Article last updated 05/02/2017 - 10:29am.

  10. An exploratory clinical trial of bortezomib in patients with lower risk myelodysplastic syndromes

    ... March 31, 2017 Myelodysplastic syndromes (MDSs) are characterized by ineffective hematopoiesis and ...

    Research Article last updated 05/02/2017 - 10:33am.